Developed by U.S. and Chinese researchers, the artificial intelligence (AI) program has been tested at two hospitals in China with 53 patients who were diagnosed in January with COVID-19. The new tool is considered experimental and is now in testing.
from WebMD Health https://www.webmd.com/lung/news/20200330/ai-might-spot-at-risk-covid-19-patients?src=RSS_PUBLIC
0 Comments:
Post a Comment